Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors

New England Journal of Medicine

Volumn 365, Issue 18, 2011, Pages 1684-1692

  Leissinger, Cindy ^a   Gringeri, Alessandro ^b   Antmen, Bul̈ent ^h   Berntorp, Erik ^k   Biasoli, Chiara ^c   Carpenter, Shannon ^l   Cortesi, Paolo ^d   Jo, Hyejin ^m   Kavakli, Kaan ⁱ   Lassila, Riitta ⁿ   Morfini, Massimo ^e   Neǵrier, Claude ^o   Rocino, Angiola ^f   Schramm, Wolfgang ^p   Serban, Margit ^q   Uscatescu, Marusia Valentina ^r   Windyga, Jerzy ^s   Zul̈fikar, Bul̈ent ^j   Mantovani, Lorenzo ^d,g  

^a TULANE UNIVERSITY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c BUFALINI HOSPITAL   (Italy)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e CAREGGI UNIVERSITY HOSPITAL   (Italy)

^f San Giovanni Bosco Hospital   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h CUKUROVA UNIVERSITY   (Turkey)

ⁱ EGE UNIVERSITY   (Turkey)

^j ISTANBUL UNIVERSITY   (Turkey)

^k LUND UNIVERSITY   (Sweden)

^l UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^m IQVIA   (United States)

ⁿ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^o UNIVERSITÉ LYON 1   (France)

^p UNIVERSITY OF MUNICH   (Germany)

^q Emergency Clinic for Children   (Romania)

^r FUNDENI CLINICAL INSTITUTE   (Romania)

^s INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 8 INHIBITOR;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLEEDING DISORDER; BODY WEIGHT; BRAIN HEMORRHAGE; CATHETER INFECTION; CHILD; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG INFUSION; DRUG SAFETY; DRUG WITHDRAWAL; ECCHYMOSIS; FEVER; GASTROINTESTINAL HEMORRHAGE; HEMARTHROSIS; HEMOPHILIA A; HUMAN; INFLUENZA; JOINT SWELLING; MUSCLE BLEEDING; PAIN; PHARYNGITIS; PHLEBITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; RISK REDUCTION; STAPHYLOCOCCUS INFECTION; SUBDURAL HEMATOMA; THORAX PAIN; TONGUE HEMORRHAGE; TREATMENT OUTCOME; UPPER ABDOMINAL PAIN; VOMITING;

EID: 80455144639     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1104435     Document Type: Article

References (30)

1. DiMichele D. Inhibitors: resolving diagnostic and therapeutic dilemmas. Haemophilia 2002;8:280-7.
2. Brackmann HH, Schwaab R, Effenberger W, Hess L, Hanfland P, Oldenburg J. Antibodies to factor VIII in hemophilia A patients. Vox Sang 2000;78:Suppl 2:187-90.
3. Leissinger CA. Prevention of bleeds in hemophilia patients with inhibitors: emerging data and clinical direction. Am J Hematol 2004;77:187-93. (Pubitemid 39281867)
4. Astermark J, Donfield SM, DiMichele DM, et al. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 2007;109:546-51. (Pubitemid 46105952)
5. Ho AY, Height SE, Smith MP. Immune tolerance therapy for haemophilia. Drugs 2000;60:547-54.
6. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003;102:2358-63. (Pubitemid 37193570)
7. Scalone L, Mantovani LG, Mannucci PM, Gringeri A. Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors. Haemophilia 2006;12:154-62.
8. Antunes SV, Vicari P, Cavalheiro S, Bordin JO. Intracranial haemorrhage among a population of haemophilic patients in Brazil. Haemophilia 2003;9:573-7. (Pubitemid 37236092)
9. Valentino LA, Martinowitz U, Doolas A, Murali P. Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A. Haemophilia 2006;12:541-4. (Pubitemid 44227599)
10. Löfqvist T, Nilsson IM, Berntorp E, Pettersson H. Haemophilia prophylaxis in young patients - a long-term follow-up. J Intern Med 1997;241:395-400. (Pubitemid 27244664)
11. Aledort LM, Haschmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 1994;236:391-9. (Pubitemid 24323199)
12. Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007;357:535-44. (Pubitemid 47236278)
13. Hilgartner MW, Makipernaa A, DiMichele DM. Long-term FEIBA prophylaxis does not prevent progression of existing joint disease. Haemophilia 2003;9:261-8. (Pubitemid 36622026)
14. Leissinger CA, Becton DL, Ewing NP, Valentino LA. Prophylactic treatment with activated prothrombin complex concentrate (FEIBA) reduces the frequency of bleeding episodes in paediatric patients with haemophilia A and inhibitors. Haemophilia 2007;13:249-55. (Pubitemid 46746047)
15. Valentino LA. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series. Haemophilia 2009;15:733-42.
16. Idem. Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors. Haemophilia 2010;16:263-71.
17. Louis TA, Lavori PW, Bailar JC III, Polansky M. Crossover and self-controlled designs in clinical research. N Engl J Med 1984;310:24-31. (Pubitemid 14212477)
18. Grizzle JE. The two-period change-over design an its use in clinical trials. Biometrics 1965;21:467-80.
19. Konkle BA, Ebbesen LS, Erhardtsen E, et al. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007;5:1904-13. (Pubitemid 47288949)
20. Bohn RL, Aledort LM, Putnam KG, Ewenstein BM, Mogun H, Avorn J. The economic impact of factor VIII inhibitors in patients with haemophilia. Haemophilia 2004;10:63-8. (Pubitemid 38195627)
21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97. (Pubitemid 41127293)
22. Jiménez-Yuste V, Alvarez MT, Martín-Salces M, et al. Prophylaxis in 10 patients with severe haemophilia A and inhibitor: different approaches for different clinical situations. Haemophilia 2009;15:203-9.
23. Ettingshausen CE, Kreuz W. Early long-term FEIBA prophylaxis in haemophilia A patients with inhibitor after failing immune tolerance induction: a prospective clinical case series. Haemophilia 2010;16:90-100.
24. Martinowitz U, Heim M, Tadmor R, et al. Intracranial hemorrhage in patients with hemophilia. Neurosurgery 1986;18:538-41. (Pubitemid 16076294)
25. Nuss R, Soucie JM, Evatt B. Changes in the occurrence of and risk factors for hemophilia-associated intracranial hemorrhage. Am J Hematol 2001;68:37-42. (Pubitemid 32738717)
26. Revel-Vilk S, Golomb MR, Achonu C, et al. Effect of intracranial bleeds on the health and quality of life of boys with hemophilia. J Pediatr 2004;144:490-5. (Pubitemid 38457353)
27. Darby SC, Keeling DM, Spooner RJ, et al. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99. J Thromb Haemost 2004;2:1047-54.
28. Traivaree C, Blanchette V, Armstrong D, Floros G, Stain AM, Carcao MD. Intracranial bleeding in haemophilia beyond the neonatal period - the role of CT imaging in suspected intracranial bleeding. Haemophilia 2007;13:552-9. (Pubitemid 47337996)
29. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br J Haematol 2008;140:378-84.
30. Gringeri A, Lundin B, von Mackensen S, Mantovani L, Mannucci PM. A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study). J Thromb Haemost 2011;9:700-10.